Cyclooxygenase-2 (COX-2) as a predictive marker for the use of COX-2 inhibitors in advanced non-small-cell lung cancer

Martin J. Edelman, Lydia Hodgson, Xiaofei Wang, Robert A. Kratzke, Everett E. Vokes

Research output: Contribution to journalArticlepeer-review

22 Scopus citations
Original languageEnglish (US)
Pages (from-to)2019-2020
Number of pages2
JournalJournal of Clinical Oncology
Volume30
Issue number16
DOIs
StatePublished - Jun 1 2012

Cite this